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ABSTRACT
The J-binding protein 1 (JBP1) is essential for bio-
synthesis and maintenance of DNA base-J (b-D-
glucosyl-hydroxymethyluracil). Base-J and JBP1
are confined to some pathogenic protozoa and are
absent from higher eukaryotes, prokaryotes and
viruses. We show that JBP1 recognizes
J-containing DNA (J-DNA) through a 160-residue
domain, DB-JBP1, with 10000-fold preference over
normal DNA. The crystal structure of DB-JBP1
revealed a helix-turn-helix variant fold, a ‘helical
bouquet’ with a ‘ribbon’ helix encompassing the
amino acids responsible for DNA binding. Mutation
of a single residue (Asp525) in the ribbon helix
abrogates specificity toward J-DNA. The same
mutation renders JBP1 unable to rescue the
targeted deletion of endogenous JBP1 genes in
Leishmania and changes its distribution in the
nucleus. Based on mutational analysis and
hydrogen/deuterium-exchange mass-spectrometry
data, a model of JBP1 bound to J-DNA was con-
structed and validated by small-angle X-ray scatter-
ing data. Our results open new possibilities for
targeted prevention of J-DNA recognition as a
therapeutic intervention for parasitic diseases.
INTRODUCTION
Base J (1), b-D-glucosyl-hydroxymethyluracil, is a
hypermodiﬁed base present in all kinetoplastid ﬂagellates
studied (2), including the Trypanosoma, Leishmania and
Crithidia genera and in Euglena (3), but absent from
other eukaryotes, prokaryotes and viruses [reviewed in
(4,5)]. J is a minor base replacing about 0.5% of T in
the nuclear DNA of kinetoplastida (6,7) and is mainly
present in the telomeric repeat sequence (GGGTTA)n
(2,8). Small amounts of J are also found in other repetitive
sequences of Trypanosoma brucei, such as the expression
sites of variant surface glycoprotein (VSG) genes (9) and
in sequences between transcription units (10).
Synthesis of the J nucleotide (11) and J-base containing
(J-DNA) oligonucleotides by chemical methods (12,13),
allowed the identiﬁcation of a 93kDa J-binding protein
1 (JBP1) in extracts of T. brucei, Leishmania species and
Crithidia fasciculata (14). JBP1 binds speciﬁcally to base
J in duplex DNA (15). JBP1 is essential in Leishmania
(16), but not in T. brucei. The absence of JBP1 in
T. brucei has no effect on growth, DNA repeat stability
or gene expression, but does result in a 20-fold decrease in
J level relative to wild-type cells (17). This led to the hy-
pothesis that JBP1 catalyzes the Erst and rate-limiting step
in J biosynthesis, the hydroxylation of T in DNA.
This hypothesis was supported by the identiﬁcation of
a weak sequence similarity between JBP1 and Fe
2+ and
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(dioxygenases) (18). Indeed, replacement of each of the
four amino acids known to be essential for hydroxylase
activity resulted in mutant proteins unable to complement
JBP1 function in either T. brucei or Leishmania, but still
able to bind to J-DNA. This showed that thymidine
hydroxylase activity and J-DNA binding are independent
functions of JBP1 (18,19).
There is one other protein in kinetoplastid ﬂagellates
which partially shares sequence similarity with JBP1,
J-binding protein 2 (JBP2). JBP1 and JBP2 share 34%
identity in their N-terminal halves (20), which contains
the thymidine hydroxylase function of JBP1 (18) and of
JBP2 (21,22). The C-terminal half of JBP2, but not of
JBP1, contains a region similar to proteins with SWI2/
SNF2-like chromatin remodeling activity. Although
JBP2 contributes to J biosynthesis (10,21,22), it is not es-
sential in T. brucei or in Leishmania and there is no
evidence that JBP2 can bind to J-DNA (20).
Although JBP1 and JBP2 are unique proteins, a distant
homolog of the JBP1/2 hydroxylase domain was recently
identiﬁed in the mammalian protein TET1 (23,24), a
fusion partner of the MLL gene in acute myeloid
leukemia. TET1 and the related TET2 and TET3
proteins catalyze the conversion of 5-methylcytosine in
DNA to 5-hydroxymethylcytosine, a reaction that may
play an important role in the epigenetic control of gene
expression (23). JBP and TET proteins have been grouped
together in the TET/JBP subfamily of dioxygenases (25).
The binding of JBP1 to J-DNA has been studied by
various methods. Using J-containing duplex oligonucleo-
tides in a gel retardation assay, it was shown that JBP1
binds to J-containing oligonucleotides with an afﬁnity
between 40 and 140nM (15). A ﬂuorescence anisotropy
polarization assay (FP) (26) yielded afﬁnities as low as
13nM. Binding to J-DNA is highly speciﬁc, since compe-
tition assays using gel-retardation indicated that a
500-fold excess of T-DNA could not out-compete
J-speciﬁc DNA binding (27). The FP assay showed an
afﬁnity for T-DNA  100 times lower than that for
J-DNA (1370nM compared to 13nM). The mode of inter-
action of JBP1 with J-DNA has been probed with several
biochemical methods (15,27). Substitution of the
hydroxymethylU in the J-base by hydroxymethylC,
resulted in a 17-fold decrease in J-binding, showing that
the pyrimidine base to which the glucose is attached
co-determines binding afﬁnity. At least 5bp on both
sides of J-base are required for optimal binding of JBP1,
although critical contacts are restricted to two bases:
major and minor groove contacts with base J and a
sequence-independent major groove contact with the
base immediately 50 of base J on the same strand
(position J-1) (27). Subsequent studies in which the
sugar moiety of base J was systematically varied, have
suggested a speciﬁc role for nucleotide J-1: its
non-bridging phosphoryl oxygen hydrogen bonding to
the equatorial 2- and 3-hydroxyl groups of the pyranosyl
ring of the glucose of base J and locking the glucose in an
‘edge-on’ conformation perpendicular to the plane of the
major DNA groove (26).
To determine exactly how JBP1 binds to J-DNA,
three-dimensional molecular structures are required. As
the ﬁrst step toward this goal, we have identiﬁed a
160-residue autonomous folding unit (domain),
DNA-Binding JBP1 domain (DB-JBP1), which binds to
J-DNA with approximately the same afﬁnity and speciﬁ-
city as full-length JBP1. We have determined the crystal
structure of DB-JBP1, revealing a novel ‘helical bouquet’
fold and suggesting a model for the interaction with
J-DNA. Hydrogen/deuterium exchange (HDX) mass
spectrometry (MS) experiments probing the interaction
between full length JBP-1 and J-DNA, showed that all
signiﬁcant changes upon binding of J-DNA were all
within speciﬁc regions of the DB-JBP1 domain only.
With site-directed mutagenesis and binding studies, we
show that a single aspartate residue in JBP1 is essential
for speciﬁc J-base recognition in vitro and for the function
of JBP1 in vivo. Finally, based on all the data above, we
constructed a structural model for the binding of
DB-JBP1 to J-DNA, which was conﬁrmed by small
angle X-ray scattering (SAXS) measurements of the
complex between JBP1 and J-DNA in solution.
MATERIALS AND METHODS
Expression and puriﬁcation of recombinant proteins
The JBP1 coding sequences from the Leishmania species
tarentolae, major, aethiopica, donovani, infantum and from
T. brucei and C. fasciculata were ampliﬁed by PCR
methods using Pfu polymerase (Stratagene) and inserted
by ligation independent cloning in our in-house pET
vector derivative, containing a hexa-histidine tag and an
HRV 3C protease site. Clones were tested for the produc-
tion of soluble protein in a heterologous Escherichia coli
expression system. While JBP1 from C. fasciculata
(Cf-JBP1) was obtained in large amounts, as expected
from previous experience (15), the only other JBP1 made
in E. coli in soluble form was the one from Leishmania
tarentolae (Lt-JBP1) from a codon optimized gene.
For large-scale preparations, vectors were transformed
to Bl21(DE3)T1
R cells and grown in the presence of kana-
mycin. Protein production was induced with 0.3mM
IPTG at 15 C at an optical density of  0.8 for 16–18h.
Cell pellets were obtained by centrifugation at 4000rpm
and lysed with the pneumatic homogenizer EmulsiFlex-C5
in 20mM Hepes pH 7.5, 350mM NaCl, 1mM TCEP,
10mM Imidazole (Buffer A), plus a tablet of Complete
EDTA-free (Roche) at 4 C. After clearing the supernatant
by centrifugation, the proteins were bound in batch to
Ni-chelating sepharose beads for 30min at 4 C (GE
Healthcare), washed with Buffer A and eluted in Buffer
A containing 400mM Imidazole. Fractions were analyzed
by SDS–PAGE.
The JBP1 elution fractions were cleaved with 3C
protease overnight at 4 C and applied to a S75 16/60 gel
ﬁltration column. Yields were between 5 and 50mg/l of
culture, depending on the construct. All proteins were
>95% pure as judged by SDS–PAGE.
All truncation constructs were ampliﬁed by PCR using
Pfu polymerase (Stratagene) and cloned for expression in
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Site-speciﬁc mutants were created using the
QuickChange (Stratagene). Expression and puriﬁcation
experiments were carried out as for full-length JBP1.
Multi-angle laser light scattering
Multi-angle laser light scattering (MALLS) experiments
were performed in a Superdex 200 HR 10/30 column
attached to an Akta FPLC and coupled to a
miniDAWN light scattering detector (Wyatt
Technology) and a Dn-1000 differential refractive index
detector (WGE Dr Bures). Hundred microliter of
puriﬁed Lt-JBP1 at a concentration of  5.0mg/ml were
injected onto the column. Data analysis were carried out
with the program Astra using a dn/dc value of 0.185.
Analytical size exclusion chromatography
Size exclusion chromatography experiments were per-
formed with a Superdex 200 3.2/30 column attached to
an Akta Puriﬁer system from GE Healthcare. For
Cf-JBP1 alone, we diluted 10mlo fa 50mM stock of
protein (0.5nmol) in a total volume of 50ml of buffer
(20mM Hepes/HCl pH 7.0 and 200mM NaCl) to a con-
centration of  10mM and injected that in the column. The
elution volume (1.50ml) indicated a size of approximately
100kDa. Subsequently, a J-containing oligonucleotide
with the sequence TAACCCJAACCCCTA was annealed
with its complementary strand and concentrated to about
50mM. A small amount of protein (1ml of the protein
stock above,  0.1nmol) was mixed with a ﬁve times
molar excess of the concentrated oligonucleotide (5ml,
 0.5nmol) in a total buffer volume of 50ml as above
and injected onto the column under identical conditions.
The molar excess of oligonucleotide was used to ensure
that all of JBP1 was bound to J-DNA. The elution volume
of the JBP1:J-DNA complex (1.48ml) was very close to
that of JBP1 alone (1.50ml). However, the shift in the
absorbance at 260 and 280nm wavelength, clearly
indicated that in the JBP1:J-DNA mixture, the peak cor-
responds to a protein:DNA complex. Using the theoretic-
al molar extinction coefﬁcients for JBP1 (e=101855) and
for the oligonucleotide (e=169000), we calculate a stoi-
chiometric ratio (28) of 1:1.01, that clearly indicated that
Cf-JBP1 recognizes J-base containing DNA as a
monomer.
Fluorescence polarization anisotropy assays
A single-stranded J-containing oligonucleotide with the
sequence 50-GGCAGCJGCAACAA-30 was synthesized
as we previously described (26), together with its
T-containing equivalent GGCAGCTGCAACAA. A
common complementary oligonucleotide was synthesized
labeled in the 50 with tetramethylrhodamine. Both comple-
mentary pairs of oligonucleotides were dissolved in water
and heat-annealed to yield J-DNA or T-DNA and the
duplex DNA was puriﬁed over a Superdex-75 10/30
Hi-Load gel ﬁltration column. Dye concentration was
determined through UV–VIS measurements and the
double-stranded oligonucleotides were calibrated against
the standard curve. The binding reaction was carried out
with 1nM TAMRA-labeled DNA, 20mM HEPES pH
7.5, 140mM NaCl (unless otherwise indicated for the
salt dependence experiments), 1g/l chicken ovalbumin,
2mM MgCl2 and 1mM TCEP. The maximum possible
amount of all JBP1 protein variants was added and sub-
sequent dilutions were achieved by serial 1:1-dilutions in
three repeats. The reaction was incubated for 10min at
4 C and room temperature before the measurements.
Measurements were performed on an EnVision 2101
multilabel reader (Perkin Elmer) using 96-well optiplates
(Perkin Elmer). The excitation ﬁlter was a Perkin Elmer
X531 with a CWL of 531nm, while the P and S emission
ﬁlter were M579p with a CWL of 579nm. All measure-
ments were preformed at room temperature.
Reverse footprinting
Cf-JBP1 alone or mixed with J-DNA were prepared inmg
amounts and digested with several proteases and in
various conditions. Fragments of the Cf-JBP1:J-DNA
mixture resistant to proteolysis, which were not present
when JBP1 alone was digested under identical conditions,
were obtained using a ratio of trypsin:Cf-JBP1 of 1:50 and
an incubation of 30min on ice.
The digested mixture was applied to a 1% agarose gel in
TBE and run for 30min at 100V. Ethidium bromide and
Coomassie blue were used to visualize the DNA and
protein, respectively, in the same gel. The region of the
agarose gel containing the protein bound to shifted DNA
was isolated and the protein was eluted by melting the
agarose gel slice under mild conditions. The eluate was
size-fractionated by polyacrylamide gel electrophoresis in
a 12% tris–glycine gel and transferred on a PVDF
membrane in Tris–Glycine–SDS–Methanol buffer for 1h
at 100V. The membrane was stained with Ponceau S and
the band was cut out and sent for N-term sequencing; it
showed the unique sequence (-)VTSSG (Cambridge
Peptides, UK).
Crystallization of DB-JBP1
DB-JBP1 was crystallized using a robotic setup we have
described previously (29). Clustered needle-like crystals
grew at 4 C overnight in 20% w/v PEG 8000, 0.2M
MgCl2 and 0.1M Tris pH 8.5, were crashed and used as
seeds for a new screening round that gave bigger single
crystals in 20% w/v PEG 3350 and 0.2M potassium
nitrate. These new crystals were used as seeds for a new
screening round with selenomethionine substituted protein
to obtain thick hexagonal plates with sharp edges in
15–20% w/v PEG 6000 and 0.2M potassium nitrate.
These crystals were transferred into a solution containing
mother liquor supplemented with 20% glycerol, mounted
in litho-loops and vitriﬁed in liquid nitrogen for diffrac-
tion studies. Crystals from the various rounds of improve-
ment are shown in Supplementary Figure S1.
Crystallographic structure determination of DB-JBP1
Crystallographic statistics are shown in Table 1. X-ray
diffraction data were collected at a wavelength of
0.978A ˚ at the SLS beamline PXI, integrated with XDS
(30) and scaled using SCALA (31). Positions of the
Nucleic Acids Research, 2011,Vol.39, No. 13 5717selenium atoms were identiﬁed with phenix.hyss (32) that
picked up seven sites. Substructure reﬁnement and com-
pletion was performed in PHASER (33). Phase probabil-
ity distributions were modiﬁed using DM; at this point the
enantiomeric space group P6122 was chosen as correct.
Automated model building with ARP/wARP 7.0 (34)
using the SAD likelihood reﬁnement function (35)
resulted in 136 residues distributed in two chains. The
model was completed manually using COOT (36),
interspersed with reciprocal space reﬁnement cycles in
REFMAC5 (37), using bulk solvent scaling, non-polar
hydrogens and four TLS groups. The ﬁnal model was
validated using WHATCHECK (38) and the MolProbity
(39) server and is of excellent quality without any
Ramachandran outliers, ranking in the 95th best percent-
ile of PDB structures in that resolution. The model is de-
posited in the PDB with code 2XSE.
Structure similarity searches
Structure similarity searches were carried out with two
methods. SSM searches (40) against the whole PDB,
after changing default search values as to the server sug-
gestions, returned some similar structures with low signiﬁ-
cance scores. The top-hit, however (3FDQ), displayed an
RMSD between Ca-atoms of matched residues of 3.25A ˚
over a length of 84 residues and a statistical signiﬁcance
Z-score of 1.3, despite a very low sequence identity of 6%
in the aligned regions and a P-score (minus logarithm of
the probability of achieving the same or better quality of
match at a chance) of zero. All other SSM hits had
Z-scores below 1.0. DALI searches, however (41),
returned the same hit in the second position in the list
ranked by Z-score, with a signiﬁcance Z-score of 5.3
and similar alignment metrics as SSM. All other DALI
hits were helical proteins but with different connectivity
than our query structure. Manual inspection of the SSM
and DALI structural alignments clariﬁed that both the
MogR structure (3FDQ) and DB-JBP1 had identical con-
nectivity in the core four helices and we thus considered
the two domains as structural homologs.
HDX MS
Solution phase amide HDX experiments were performed
with a LEAP technologies (Carroboro, NC, USA) CTC
HTS twin PAL autosampler interfaced with an
electrospray ionization (ESI) linear ion trap mass spec-
trometer (Thermo Electron, San Jose, CA, USA) (42).
Of a 11mM JBP1 stock solution (0.7M NaCl, 15mM
KCl, pH 7.0), 4ml were diluted with 16ml of an equivalent
composition D2O buffer and incubated for 1, 30, 60, 900
and 3600s to allow H/D exchange to occur. Following the
allotted time period, the sample was diluted to 50ml with
cold (1.5 C) 2M urea containing 0.1% TFA. Protein was
then passed through an immobilized pepsin column
(2mm 2cm made in-house) held at 1.5 C and the result-
ant peptides were captured on a C8 peptide micro trap
(Michrom Bioresources, Inc., Auburn, CA, USA).
Peptides were then eluted across an HPLC column
(Betasil C18 50 2.1mm, 5mm) into the ESI source with
a gradient of 2% CH3CN increasing to 50% CH3CN over
18min. For the JBP1+J-DNA experiment, 11mM JBP1
stock solution was incubated with a J-base containing syn-
thetic oligonucleotide prior to mixing with D2O buffer and
subsequent analysis. Data represent the average of three
replicates and were processed with in-house developed
software (43).
Surface plasmon resonance assays
Surface plasmon resonance (SPR) spectroscopy was per-
formed at 25 C on a Biacore T100. Oligonucleotides were
prepared as described for the FP assays, but with a
biotin-TEG labeled complementary strand, that was
used to immobilize them on a streptavidin chip (SA, GE
Healthcare). Concentrations series of all proteins were
injected across the chip in a PBS buffer pH 7.4, with
0.05% (w/v) Tween-20 at a ﬂow rate of 30ml/min. The
concentrations used were between 32 and 0.25mM for all
DB-JBP1 variants. Binding curves were recorded for each
protein, using an empty ﬂow cell as reference. All experi-
ments were repeated at least twice in a non-sequential
manner to exclude systematic errors. The Biacore T100
evaluation software was used for the initial data analysis.
Testing the function of the JBP1 D525A mutant in vivo
JBP1 is essential in L. tarentolae for making J-base (16)
and this complicates the testing of mutant versions of
JBP1. We have used the procedure that was described in
(18) to test the hydroxylation activity of JBP1 in a rescue
experiment. The principle of this experiment is schematic-
ally outlined in Supplementary Figure S2. One of the two
alleles of the JBP1 gene in L. tarentolae was disrupted ﬁrst
with a JBP1 KO puromycin construct. The resulting
JBP1
+/  cells were selected with puromycin and subse-
quently transfected with plasmids containing either the
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were then selected with paromomycin, as these plasmids
also contain a neomycin marker. Next, the second JBP1
allele was targeted with a JBP1 KO hygromycin construct.
JBP1
 /  cells were then selected with puromycin and
hygromycin and paromomycin was added to ensure reten-
tion of the rescue plasmid containing either wild-type or
mutant JBP1.
Numerous colonies were obtained with the cells con-
taining the rescue plasmid with wild-type JBP1. NcoI re-
striction digests of the DNA of some of these colonies
were hybridized with a radioactive probe, corresponding
to the 30-UTR of the JBP1 gene that is not present in the
rescue gene of the plasmids. The blots were used to
identify the endogenous JBP1 gene or the rescue con-
structs as outlined in Supplementary Figure S3. In six
out of the eight clones, the band corresponding to the
endogenous JBP1 gene was not present (Supplementary
Figure S3), indicating a complete disruption of both JBP1
alleles and has a reasonable efﬁciency of the rescue
plasmid. Only few clones were obtained when the JBP1
D525A rescue plasmid was used for rescue, already
indicating that this mutant is inefﬁcient in rescuing the
endogenous JBP1 gene disruption. All of these clones
had retained a wild-type JBP1 gene band, as shown in
Supplementary Figure S3 (lanes 11–18); duplication of
the endogenous wild-type JBP1 gene, is an expected
reaction of Leishmania, as reported (16,18).
To verify that JBP1 protein was actually produced in
sufﬁcient amounts in the transfected cells, we quantiﬁed
the amount of JBP1 by western blotting. Supplementary
Figure S4 shows that some of the mutant rescue clones
produced high amounts of JBP1. The localization of that
protein was subsequently assessed by ﬂuorescence micros-
copy. For ﬂuorescence microscopy, wild-type L. tarentolae
and cells overproducing the D525A mutant protein were
ﬁxed on the same slide with 1% formaldehyde in PBS,
blocked with 1  blocking solution (Roche). Primary
(a-JBP1) and secondary (Alexa 488 conjugated goat
a-rabbit) antibodies were incubated in 3% BSA/PBS at
37 C. Slides were mounted in Vectashield solution
(Vector Laboratories). The DNA was stained with
Topro3 DNA stain (invitrogen). Images were captured
with a Leica TCS SP2 AOBS confocal microscope.
Details of the procedure are described in (22); the
a-JBP1 antibody was described in Ref. (6).
Modeling of the DB-JBP1 complex
The complex of MogR with DNA (3FDQ) was used as the
template to create a model of the binding of DB-JBP1 to
J-DNA. First, the recognition helix of DB-JBP1 (517–525)
was superposed to the recognition helix of MogR using
COOT (36). Then, a model for J-DNA was created as a
standard 20-mer B-DNA with the sequence used for the
SAXS experiment. A 3bp fragment of J-DNA from the
molecular dynamics simulations that suggested the speciﬁc
conformation of J-base in the major groove (26) was then
grafted to the 20-mer DNA to create a J-DNA 20-mer,
with J at position 12. The geometry of that structure was
idealized in REFMAC5 (37) using interval restraints (44)
for describing the hydrogen bonds of the J-base to the
N-1-phosphoryl oxygen and between all other Watson–
Crick base pairs. The 7nt bracketing the J-base in the
J-containing strand (9–15) of this idealized 20-mer were
then superposed to the DNA in the MogR complex,
‘sliding’ it in various positions to ﬁnd a placement that
would allow the J-base to be located close to Asp525 of
the recognition helix; a unique suitable solution was found
and was used to create the DB-JBP1:J-DNA complex. In
that complex, both C4 and C6 hydroxyls were very close
to Asp525, whereas Arg517, Lys522, Lys524 were all close
to DNA and available for interactions. That encouraged
us to model the loop missing from the structure, residues
529–534, in a conformation where Arg532 was also in
contact with DNA; a suitable stereo-chemically allowed
conformation was easily identiﬁed using COOT. The
ﬁnal model geometry was idealized with REFMAC5 and
was then compared against the SAXS experimental data
and showed an excellent ﬁt.
SAXS data collection and analysis
The same DB-JBP1 protein as used for crystallization was
also used for the SAXS experiments. DB-JBP1 and double
stranded J-DNA oligonucleotides with the sequence 50-CA
GAAGGCAGCJGCAACAAG-30 were created as
described above, mixed at a 1:1 molar ratio and the
complex was puriﬁed by size exclusion chromatography.
Two concentrations of DB-JBP1 alone (1.48 and 2.58mg/
ml) and three concentrations of the complex between
DB-JBP1 and J-DNA (2.1, 2.5 and 6mg/ml) were
measured at the X13 beamline at the EMBL-Hamburg
and all data were possessed by PRIMUS (45). The agree-
ment between the experimental scattering curves and the
structure of DB-JBP1, the model of DB-JBP1 bund to
J-DNA and J-DNA alone were evaluated using
CRYSOL (46). The ab initio model for the
DB-JBP1:J-DNA complex was created by DAMMIF (47).
RESULTS
JBP1 binds to J-DNA ten thousand times stronger
than to T-DNA
We have produced large amounts of JBP1 from
C. fasciculata (Cf-JBP1) (15) and from L. tarentolae
(Lt-JBP1) using a synthetic gene. Both Lt-JBP1 and
Cf-JBP1 were puriﬁed with standard chromatographic
methods as described in Materials and Methods. The
high quality proteins obtained were used for all subse-
quent assays. Initial characterization experiments were
performed with Cf-JBP1; most subsequent experiments
were done with Lt-JBP1.
The molecular mass of both Cf-JBP1 and Lt-JBP1 was
determined by MALLS, showing that both are monomers
in solution (Supplementary Figure S5A). JBP1 also
binds to DNA as a monomer, as indicated by size exclu-
sion chromatography experiments using Cf-JBP1
(Supplementary Figure S5B).
Protein–DNA binding is typically dominated by
hydrogen bonding and electrostatic interactions, which
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J-DNA binding afﬁnity on salt concentration. For this
assay, we used a FP setup, similar to the one described
in (26). The binding of JBP1 to a DNA sequence derived
from the VSG gene, containing a J or a T nucleotide,
exhibits a strong dependence on salt concentration
(Figure 1A–C). The maximal discrimination between
J-DNA and T-DNA takes place around physiological
salt conditions and is about ten thousand times, with a
KD for J-DNA of 11.1nM and for T-DNA of 83mM
(Figure 1C and Supplementary Table S1).
A small domain of JBP1, DB-JBP1, is sufﬁcient for
speciﬁc J-DNA recognition
To determine whether a speciﬁc domain of JBP1 is respon-
sible for J-DNA recognition, we performed a ‘reverse
footprint’ experiment. Cf-JBP1 was mixed with J-DNA
in microgram amounts and treated with limiting
amounts of protease in an attempt to identify a protein
domain that becomes resistance to proteolysis upon
J-DNA binding. We found conditions in which
J-DNA-bound JBP1 produced fragments resistant to pro-
teolysis, which were not present when JBP1 alone was
digested under identical conditions (Figure 2A). The
digested mixture was used in a non-radioactive agarose
gel retardation assay with J-containing oligonucleotide.
We identiﬁed a clear band of shifted J-DNA
(Figure 2B). This band migrated faster than the control
J-DNA bound by full-length JBP1 and overlapped with a
protein band (Figure 2B), suggesting that a small
proteolysis-resistant fragment was responsible for the
band shift. This fragment was identiﬁed by N-terminal
protein sequencing to start at residue 382, while a com-
bination of molecular weight information, secondary
structure predictions and alignments allowed us to also
deﬁne the most likely C-terminus at residue 561
(Figure 2C and D). This domain was termed DNA
Binding JBP1 domain (DB-JBP1).
The DB-JBP1 domain was produced in E. coli and
yielded large amounts of soluble protein. We compared
the binding of the Leishmania DB-JBP1 and full-length
Lt-JBP1 to J-DNA using the ﬂuorescent polarization
assay (Supplementary Figure S6 and Table S1).
DB-JBP1 binds to J-DNA with an afﬁnity about three
times less than full-length JBP1 (32.9nM compared to
11.1nM) and to T-DNA with a marginally lower afﬁnity
(129mM compared to 83mM; Supplementary Table S1).
The discrimination between J-DNA and T-DNA at
physiological salt concentrations is about the same for
both JBP1 and DB-JBP1 (Supplementary Table S1).
The crystal structure of the DB-JBP1 domain
The DB-JBP1 structure was determined using Se-Met
substituted DB-JBP1 in a single-wavelength anomalous
dispersion (SAD) experiment and reﬁned to yield a
model with all residues in favorable regions of the
Ramachandran plot and an Rfree of 20.3% (Table 1).
The ﬁnal model does not contain the ﬁrst 13 residues
(382–394) and six residues in the loop between residues
528 and 535, which could not be modeled in the electron
density and are presumably disordered.
The structure of DB-JBP1 is a helical bundle in an ar-
rangement we call a ‘helical bouquet’ (Figure 3A and B).
The fold is made by ﬁve helices, of which the four longest,
a1, a2, a3 and a5 run antiparallel in the same approximate
orientation (the ‘ﬂowers’ of the bouquet), with their
axes at angles of about 15 –45 . Helix a4 is perpen-
dicular to this arrangement, creating a ‘ribbon’ running
across the front. The helical bouquet appears to be a
divergent variant of the aberrant three-helical bundle
helix-turn-helix (HTH) domains, closest to the prokaryot-
ic tetra-helical bundle (Figure 3E) (48). The ribbon helix in
the DB-JBP1 helical bouquet corresponds to the recogni-
tion helix of the core three-helical bundle (a2–4) preceded
N-terminally by a long 28-residue helix (a1) and followed
C-terminally by a 19-residue helix (a5). Notably, the sup-
porting a3 helix and the recognition a4 (ribbon) helix are
Figure 1. Speciﬁcity of JBP1 for J-DNA over T-DNA is salt dependent. (A and B) Binding of varying concentrations of Lt-JBP1 to J-DNA (A) and
T-DNA (B) measured by the anisotropy of the signal of 1nM labeled DNA, for seven different (buffered) concentrations of NaCl; symbols indicate
the data points and vertical bars, the measures standard deviation; lines represent the ﬁtted function that determination of the allowed KD; for very
tight KD the ﬁt is poorer since it is likely to be far from the assumed equilibrium. (C) The ratio of the calculated KD for T-DNA over J-DNA
(indicating the speciﬁcity toward J-DNA) is shown as the function of the ionic strength of the buffer; the dotted line represents a polynomial ﬁt to
the data without assuming a physical model.
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motifs, but by an unusually extensive loop of nine
residues. The conserved ‘small-hydrophobic-small’ signa-
ture motif in the turn between helix-2 and helix-3 of the
core HTH structure (48) is conserved in the long connect-
ing loop of the JBP1 family and is directly preceding the
recognition helix (Ala-Met-Ser in Leishmania and
Crithidia and Ser-Met-Gly or Ala-Val-Gly in the
Figure 2. Identiﬁcation of the DB-JBP1 domain. (A) SDS–PAGE separation before and after limited proteolysis of the Cf-JBP1 protein alone and
bound to J-DNA; the JBP1 and DB-JBP1 bands recovered after elution from the gel after the retardation assay are also shown and DB-JBP1-1is
indicated by arrows. (B) Agarose gel DNA mobility retardation assay for JBP1 mixed with J-DNA before and after limited proteolysis, stained with
ethidium bromide and with Coomassie blue; DB-JBP1 is indicated by arrows. (C) A schematic drawing of the JBP1 sequence with the N-terminal
thymidine hydroxylase domain and the DB-JBP1 domain indicated. (D) A multiple sequence alignment of JBP1 from Leishmania, Trypanosoma and
Crithidia; the DB-JBP1 domain is boxed; fully conserved residues are in black and bold on a gray background; conserved residues are in gray and
bold; the secondary structure elements and residue numbers correspond to the L. tarantolae protein; disordered regions and peptides identiﬁed to be
in contact with DNA in the HDX-MS experiment are annotated with labeled bars; wedge indicate Lys/Arg mutations and asterisks indicate D/E
mutations (gray for no effect, black for affecting DNA binding).
Nucleic Acids Research, 2011,Vol.39, No. 13 5721Trypanosoma proteins). The ‘charged-hydrophobic-small’
motif in the supporting helix of HTH domains is absent in
JBP1.
Searches for structural homologs of DB-JBP1 in the
PDB, using either SSM (40) or DALI (41), returned a
signiﬁcant, albeit weak, structural similarity with the
HTH-domain structure of the MogR transcriptional re-
pressor of the bacterial pathogen Listeria monocytogenes
(49) (Figure 3E and Supplementary Figure S7). The
MogR structure has been determined in complex with
AT-rich DNA, with the recognition helix mediating
major groove contacts as expected. The long C-terminal
wing that mediates minor groove interaction with the
AT-rich DNA in MogR, is in DB-JBP1 the 6-residue dis-
ordered loop leading to the a5 helix that is absent in
MogR. By analogy to MogR, this disordered loop likely
gets ordered when DB-JBP1 gets in contact with DNA
and could mediate minor groove interactions.
The electrostatic surface potential of DB-JBP1 shows a
large positive patch in the surface where the recognition
helix lies, also suggesting that this is the primary area for
DNA binding (Figure 3C and D). Given, however, the low
sequence conservation (6% identity) and the large differ-
ences between superposed Ca atoms (3.2A ˚ ) between
DB-JBP1 and MogR, its closest HTH domain structural
homolog, it was impossible to reliably predict in fur-
ther detail the mode of JBP1 binding to DNA and
explain the preference for J-DNA. We therefore used
other methods to analyze the contacts of J-DNA with
the JBP1 protein.
HDX MS demonstrates the DB-JBP1 regions involved in
DNA-binding
We used HDX-MS to determine which regions of
full-length JBP1 interact with DNA. The HDX-MS
experiment measures the rate of exchange of protein
backbone amide hydrogen with deuterium. The rate
of this exchange is inﬂuenced primarily by hydro-
gen bonding and therefore operates as a sensor for the
local chemical environment of the amide hydrogen.
The deuterium exchange is plotted as a function of
time for the protein alone and is then compared to the
values obtained for protein bound to DNA. The
peptides that show reduced exchange rates upon
complex formation with DNA are, therefore, involved in
DNA binding, either directly or through allosteric
perturbation of the protein structure/dynamics. We show
that only a few peptides exhibit reduced H/D exchange
rates upon binding of JBP1 to J-DNA, all spanning
the DB-JBP1 domain (Figures 2C, 4A and B
and Supplementary File S1 for detailed results). The
most prominent changes occurred in the peptides
516–525 (helix a4, 30% reduction in exchange rate,
Figure 4A). The other peptides that showed a signiﬁcant
change upon J-DNA binding, 434–441 (helix a1, 23%),
510–515 (the loop between helices a3 and a4, 124%) and
452–463 (helix a2 and the loop before, 12%)
(Supplementary Figure S8), are also within the DB-JBP1
domain. The peptide spanning residues 593–605 that
showed a modest change (11%, Supplementary Figure
S8) is just C-terminal to DB-JBP1. Eight different
peptides that were identiﬁed in the HDX-MS experiment
corresponding to the N-terminal half of the supporting
helix a3(  484–494), which often mediates some
contacts with DNA, did not show any signiﬁcant
changes ( 2% to 2%). A few more changes, all within
the DB-JBP1 domain, had values below 10%, while no
change above 5% was observed elsewhere in JBP1
(Supplementary Figure S9).
This experiment suggests that DB-JBP1 is the only JBP1
domain involved in J-DNA binding and that it is sufﬁcient
for speciﬁc J-DNA recognition. The biggest change in
hydrogen–deuterium exchange rates upon J-DNA
binding overlaps perfectly with helix a4, conﬁrming that
Figure 3. The structure of DB-JBP1. (A) Cartoon representation of
DB-JBP1, in the orientation reminiscent of a ﬂower bouquet; each
helix is in a different color and labeled; the recognition helix is in
yellow. (B) The same cartoon after a 90  rotation along the vertical
axis. (C and D) Surface representations (in the same orientation as A
and B respectively) colored according to the electrostatic surface po-
tential ( 7 to 7 kT). (E) Schematic drawing of typical HTH domains,
DB-JBP1 and MogR, with helices drawn as cylinders; structurally
equivalent helices are drawn in the same colors used for the structure
of DB-JBP1.
5722 Nucleic Acids Research, 2011,Vol.39, No. 13Figure 4. Mapping the DB-JBP1 regions that bind DNA. (A) The peptides that show hydrogen–deuterium exchange rate differences upon J-DNA
binding are colored according to the magnitude of the differences and mapped in the DB-JBP1 structure; the insert depicts the change in hydrogen–
deuterium exchange rate of the JBP1 peptides 516–525 (which corresponds to the recognition helix a4) in the unbound and J-DNA bound state.
(B) Location of the DB-JBP1 point mutants used to identify the residues involved in J-DNA binding. (C) Binding of varying concentrations of the
various Arg/Lys mutants of DB-JBP1 to J-DNA (left) and T-DNA (right); colors are used purely to indicate the different curves more clearly.
(D) Binding of DB-JBP1 and (E) JBP1 and the corresponding D525A mutants to T-DNA and to J-DNA.
Nucleic Acids Research, 2011,Vol.39, No. 13 5723residues in this helix are the primary site for DNA
interaction.
DB-JBP1 recognizes DNA through lysine and arginine
residues in helix a4
To ﬁnd the residues that interact with the DNA backbone
we created seven point mutants in DB-JBP1 (Figure 4B),
based on structural data and the HDX-MS experiments:
R517A, K518A, K522A, K524A targeting each positively
charged residues in helix a4; R532A and K535A targeting
the intrinsically disordered loop downstream helix a4
which had an appreciable 8% decrease in the HDX-MS
data and K436A lying at the end of helix a1 that also
showed some changes in the HDX-MS data. All mutant
proteins were expressed and puriﬁed and were used in the
FP assay (Figure 4C). The R532A, K518, K522A and to a
lesser extent K524A proteins, showed decreased afﬁnity
for both J-DNA and T-DNA, suggesting that these
residues, all but one lying in the a4 ribbon helix, are
involved in DNA binding, but do not speciﬁcally recog-
nize the J-base. K436A and K535A showed no appreciable
change in afﬁnity.
A single aspartate residue is responsible for J-binding
speciﬁcity
The glucose of the J-base lies in the major groove of the
DNA and should be recognized speciﬁcally by DB-JBP1
residues. We hypothesized that aspartate or glutamate
residues could recognize the hydroxyl groups of the
glucose moiety and these should be fully conserved in
the JBP1 family. Ten such residues were located and we
created eight point mutants (since there are two pairs of
glutamates): E391A, D465A, E468A, E487/488A, D525A,
D536A, E540/541A, E553A. Five of these mutants
produced soluble protein in E. coli and were assayed in
a SPR experiment in comparison with wt DB-JBP1.
The D525A mutant protein exhibited no observable
binding to J-DNA under the SPR experimental condi-
tions, while all other mutants showed no signiﬁcant
differences compared to DB-JBP1 (Supplementary
Figure S10 and Table S1).
The D525A DB-JBP1 mutant was characterized in more
detail in the FP assay. This mutant protein has strikingly
lost nearly all discrimination for J-DNA, since its afﬁnity
for J-DNA is only 5.1mM, similar to its afﬁnity for
T-DNA, 9.7mM (Figure 4D and Supplementary Table
S1). The afﬁnity of the D5252A mutant for T-DNA
(9.7mM) has increased about 10 times compared to
wild-type DB-JBP1 ( 83mM); a possible explanation for
this observation is the removal of the repulsion between
the negatively charged aspartate carboxylates and the
DNA backbone phosphates. Consistently, the full-length
JBP1 D525A mutant has the same low afﬁnity for J-DNA
(5.1mM) and its afﬁnity for T-DNA is 11.7mM (Figure 4E
and Supplementary Table S1). These results strongly
indicate that a single residue, Asp525, is necessary and
sufﬁcient for conferring speciﬁcity toward J-DNA.
Aspartate 525 is important for in vivo function of JBP1
We tested whether the JBP1 D525A mutant can function-
ally replace wild-type JBP1 in L. tarentolae, using an
approach we previously described (18) and outlined in
Supplementary Figure S2. Leishmania tarentolae cells in
which one of the two JBP1 alleles had been inactivated by
insertion of a drug resistance marker were transfected with
plasmids expressing either wild-type or mutant JBP1.
Then, the second chromosomal JBP1 allele was
inactivated with a targeting construct containing a
second drug resistance marker. Whereas both alleles of
chromosomal JBP1 could be easily disrupted in the
presence of the rescue plasmid containing wild-type
JBP1, JBP1 D525A completely failed to rescue. Clones
were obtained containing both drug resistance markers,
but in these clones an extra copy of the wild-type gene
had appeared (Supplementary Figure S3). Generation of
additional wild-type gene copies is the standard response
of Leishmania, if attempts are made to disrupt both alleles
of an essential gene (16,50). The negative result with the
mutant JBP1 is not due to defective synthesis or routing of
the mutant protein, which is made in high amounts
(Supplementary Figure S4). The protein is reaching the
nucleus, as our anti-JBP1 antibody detects more JBP1 in
the nucleus of cells containing the rescue plasmid with
mutant JBP1 than with wild-type JBP1 (Supplementary
Figure S4). We conclude that mutant JBP1 is unable to
provide sufﬁcient JBP1 function for L. tarentolae to
survive.
Interestingly, the distribution of wild-type and D525A
mutant JBP1 in the nucleus is different. Wild-type JBP1 is
located in discrete spots (Figure 5), presumably the J-rich
telomeres of L. tarentolae, which are known to be present
in about 16 clusters in Leishmania (51). In contrast,
JBP1-D525A exhibits a more diffuse nuclear staining
pattern (Figure 5) indicating that it has lost its ability to
speciﬁcally bind J-DNA also in vivo.
A structural model for DB-JBP1 binding to J-DNA and
validation by SAXS
In the absence of a crystal structure of DB-JBP1 in
complex with J-DNA, we created a model based on the
structure of MogR with DNA (49), using interactive
graphics (see Experimental Methods). The modeled
J-DNA runs along the positive patch in JBP1
(Figure 6A) and along the patch identiﬁed by the
HDX-MS experiments (Figure 6B). In addition, Asp525
is in contact with the J-base, while the Arg/Lys residues
important for general DNA recognition are in contact
with the J-DNA backbone (Figure 6C).
To validate this model, we measured SAXS curves for
DB-JBP1 alone and in complex with J-DNA in solution,
to determine their low-resolution shape. The radius of
gyration calculated from the SAXS data for the
DB-JBP1 in complex with J-DNA (2.3nm) ﬁts well with
that calculated from our model (2.15nm). In addition, the
calculated scattering curves from the structure of
DB-JBP1 and from our model of the complex between
DB-JBP1 and J-DNA, both ﬁt very well only to their cor-
responding experimental SAXS data (Figure 6D and
5724 Nucleic Acids Research, 2011,Vol.39, No. 13Supplementary Figure S11). Furthermore, a low reso-
lution ab initio beads model created based on the
complex SAXS data is also in good agreement with our
model (Figure 6D).
DISCUSSION
Under physiological conditions, JBP1 shows a remarkable
10000-fold binding preference for J-DNA over T-DNA
with the same sequence. This is in line with the results of
Sabatini et al. (15) who showed that a 500-fold excess of
T-DNA was unable to out-compete binding of J-DNA to
JBP1. In salt concentrations lower than physiological, this
speciﬁcity is compromised, explaining previous reports
that the preference for J-DNA is only 100-fold (26).
We show that the DB-JBP1 domain, which has afﬁnity
and speciﬁcity close to that of full-length JBP1, is the only
region that mediates binding of JBP1 to J-DNA. The two
functions of JBP1 are therefore separated in two different
parts of the protein: the thymidine hydroxylase resides in
the N-terminal half and the J-DNA binding in the
C-terminal half. Cross et al. (14) raised the possibility
that a HTH motif located in the N-terminal half of
JBP1 (residues  250–260), would be involved in DNA
binding, as this motif had some similarity with the Myb
homeodomain. This hypothetical binding site is not
corroborated by our experiments.
The DB-JBP1 fold is a divergent variant of the HTH
domains family, a motif that can be traced back in 6–9
copies, with divergent functionality in the last universal
common ancestor (LUCA), and it is a common module
in many proteins and multiprotein assemblies (48). The
HTH domain in DB-JBP1 is characterized by an unusual-
ly long 9-residue ‘turn’ and the long helices that bracket
the core three-helical bundle. This helical bouquet is not
readily classiﬁable in the HTH families described. This
raises puzzling questions as to its ancestry and incorpor-
ation into the JBP1 multidomain scaffold.
The recognition helix of the HTH motif, the ribbon of
the helical bouquet, bears a single aspartate residue
(Asp-525) that appears to be the sole determinant of
J-DNA versus T-DNA recognition. It has been suggested
(26) that the C2 and C3 hydroxy groups of the J-base
glucose form hydrogen bonds with the non-bridging
pro-R phosphoryl oxygen of the J-1 nucleotide phosphate
group. In this model, the C4 and C6 hydroxy groups of
the glucose moiety are free to engage in additional
contacts. We speculate that Asp-525 is recognizing one
or both of the C4 or C6 hydroxy groups.
Our model does not point to any direct binding con-
tacts between JBP1 and the pyrimidine heterocycle of
base J. However, it has been shown that replacement
of the hydroxymethyluracil of base J with hydroxy-
methylcytosine reduces binding to JBP1  15 times (27).
This result argues that JBP1 directly recognizes the base
heterocycle, putting our model at apparent odds with the
experimental data. However, chemical intuition suggests
that a potential intramolecular hydrogen bond can be
formed between the C4 amino group of the cytosine
heterocycle and the C6 hydroxy group of the pendant
b-D-glucosyl, an interaction that cannot be established in
the native base J. This hydrogen bond would result in a
change in the overall geometry of the ‘edge on’ conform-
ation of the b-D-glucose group in the major groove, a
critical determinant of JBP1 binding (26). Therefore, in
the speciﬁc case of hydroxymethylcytosine, the reduction
in JBP1 binding can be accounted for without invoking
any recognition of the heterocycle by JBP1. The binding
of JBP1 to in vitro glucosylated hydroxymethylcytosine–
DNA is of special interest, as it has recently been used in a
new and efﬁcient method, to isolate DNA containing
hydroxymethylcytosine (52). This should help to locate
Figure 5. The D525A JBP1 mutant protein fails to localize in J-rich nuclear regions. Fluorescence microscopy images of L. tarentolae cells ﬁxed on
microscope slides and stained with anti-JBP1 antibody and TOPro3 (DNA). JBP1 in the wild-type cells (upper panel) localizes in discrete spots in the
nucleus, but the cells producing also the D525A mutant JBP1 (lower panel) show a more diffuse pattern. The bright staining DNA ovals in the cells
are the kinetoplastid DNA networks; the nuclei stain less intense. The ‘doughnut-like’ staining with anti-JBP1 antibody in the lower panel is
probably due to weaker staining of the large nucleolus, creating an apparent hole in the nucleus.
Nucleic Acids Research, 2011,Vol.39, No. 13 5725this new mammalian epigenetic marker base (24,53) more
precisely in DNA.
The D525A mutant of JBP1, in contrast to wild-type
JBP1, fails to rescue the targeted JBP1 gene deletion in
L. tarentolae. Previous work with T.brucei has shown that
introduction of wild-type JBP1 into trypanosomes without
any J in their DNA results in J synthesis (10). JBP1 is,
therefore, able to start from scratch, i.e. hydroxylate some
T-residues in T-DNA, to which it binds poorly. Once a
few initial J molecules have been made, hydroxylation can
apparently accelerate sufﬁciently to introduce substantial
amounts of J into the DNA (10). In contrast, with the
D525A mutant of JBP1 the sluggish introduction of
some J is evidently not followed by a rapid increase in J,
because mutant JBP1 is unable to bind strongly and spe-
ciﬁcally to J and hydroxylate more T’s in an efﬁcient
fashion. Highly speciﬁc J-binding is therefore an essential
prerequisite for JBP1 function. From previous experi-
ments (54), we have deduced that even 10–15% of
wild-type JBP1 function is sufﬁcient for normal multipli-
cation of L. tarentolae: it follows that D525A JBP1
provides less than 10% of wild-type function and that
DNA binding alone cannot restore the complete JBP1
function without the speciﬁc recognition and strong
binding of JBP1 to pre-existing J.
Having established that Asp525 is a residue crucial for
JBP1 function both in vitro and in vivo, we constructed a
model for JBP1 binding to J-DNA, where the ribbon helix
is positioned along the major groove of J-DNA. The
low-resolution shape of our model is consistent with
solution X-ray scattering experiments. Although the
atomic interactions in this model are in agreement with
all our mutagenesis data, the details remain to be struc-
turally validated.
JBP1 was assumed to have a ‘glucose-binding pocket’
that could be targeted by potential small molecule inhibi-
tors. Unfortunately, our model renders this possibility less
likely, since the glucose is recognized by the aspartate
residue protruding from the ‘ribbon’ helix, much in the
same manner as other helical major groove interactions
in DNA recognition. Such interactions have been notori-
ously difﬁcult to target by small-molecule inhibitors.
However, the speciﬁc charge pattern, with the acidic as-
partate surrounded by basic residues, could provide a
possible target site and a positive surprise. In addition,
small molecules or short synthetic peptide inhibitors
based on the DB-JBP1 recognition helix, targeting
J-DNA rather than JBP1, or chemicals targeting the
J-DNA conformation as previously proposed (26), might




Supplementary Data are available at NAR Online.
Figure 6. A model of JBP1 binding to J-DNA. (A) JBP1 is shown as a
surface colored by electrostatic potential; J-DNA is shown as a cartoon
with the J-base as stock model; while the DNA backbone runs along
the positive (blue) patch in the JBP1 surface, the J-base faces a negative
(red) ‘island’. (B) Same as in A but the JBP1 surface is colored by the
propensity of peptides to interact with J-DNA according to the
HDX-MS experiments, like in Figure 4A. (C) A close up of the inter-
action of JBP1 with the J-base; the residues important for interaction
according to mutagenesis studies are shown as stick models and are
labeled. (D) Validation of the model against SAXS data; the graph
shows the intensity calculated from the model (red line) and the experi-
mental data (open cyan circles) against the scattering amplitude; in the
inlet picture the pink surface represent an ab initio beads model
calculated from the SAXS data and superposed onto the
JBP1:J-DNA complex model.
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